Aigh Capital Management LLC Adverum Biotechnologies, Inc. Transaction History

Aigh Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.75 - $1.26 $1.39 Million - $2.33 Million	1,848,834 Added 139.64%	3,172,819 $2.38 Million
Q3 2023 Nov 13, 2023	SELL	$1.5 - $2.33 $239,358 - $371,802	-159,572 Reduced 10.76%	1,323,985 $1.99 Million
Q2 2023 Aug 14, 2023	BUY	$0.68 - $1.59 $192,818 - $450,855	283,557 Added 23.63%	1,483,557 $2.36 Million
Q3 2022 Nov 10, 2022	BUY	$0.96 - $9.68 $1.15 Million - $11.6 Million	1,200,000 New	1,200,000 $1.14 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.